Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer

por Penson, Richard T, Ambrosio, Allison J, Whalen, Christin A, Krasner, Carolyn N, Konstantinopoulos, Panagiotis A, Bradley, Charles, Matulonis, Ursula A, Birrer, Michael J
Publicado 2023

Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer

por Konstantinopoulos, Panagiotis A., Gockley, Allison A., Xiong, Niya, Krasner, Carolyn, Horowitz, Neil, Campos, Susana, Wright, Alexi A., Liu, Joyce F., Shea, Meghan, Yeku, Oladapo, Castro, Cesar, Polak, Madeline, Lee, Elizabeth K., Sawyer, Hannah, Bowes, Brittany, Moroney, John, Cheng, Su-Chun, Tayob, Nabihah, Bouberhan, Sara, Spriggs, David, Penson, Richard T., Fleming, Gini F., Nucci, Marisa R., Matulonis, Ursula A.
Publicado 2022